# OnCo record study-201 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/study-201/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "study-201", "NCT00168064" ;
  schema:name "Study 201"@en ;
  schema:alternateName "2005NMMF-201-US"@en, "Valchlor pivotal trial"@en ;
  schema:description "Study 201 showed that a ready-made mechlorethamine skin gel worked at least as well as a pharmacy-compounded ointment for early mycosis fungoides, and it was the main evidence for the US approval of Valchlor."@en ;
  schema:url <https://onco.cc/trials/study-201/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00168064>, <https://doi.org/10.1001/2013.jamadermatol.541>, <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6a52e4c2-6a9f-4ebb-bc77-046b4f8bcd57> ;
  onco:status "positive" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/cutaneous-t-cell-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/mechlorethamine/> ;
  onco:companies <https://onco.cc/companies/helsinn/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-study-201-jama-dermatol-2013/> .